Lee Jie-Eun, Min Se Hee, Lee Dong-Hwa, Oh Tae Jung, Kim Kyoung Min, Moon Jae Hoon, Choi Sung Hee, Park Kyong Soo, Jang Hak Chul, Lim Soo
Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Int J Cardiol. 2016 Dec 15;225:327-331. doi: 10.1016/j.ijcard.2016.10.015. Epub 2016 Oct 6.
Early detection of atherogenic dyslipidemia is crucial. We investigated lipoprotein subfraction parameters according to glucose metabolism status.
We recruited 1255 lipid-lowering drug-naïve subjects with normal fasting glucose (NFG; n=200, 15.9%), impaired fasting glucose (IFG; n=443, 35.3%), or type 2 diabetes (T2D; n=612, 48.8%). Lipoprotein subfractions (1-7) were determined by polyacrylamide gel electrophoresis, separating low-density lipoprotein (LDL) into large buoyant LDL (lbLDL, LDL1-2) and small dense LDL (sdLDL, LDL3-7). Lipoprotein subfraction parameters including the sdLDL% (LDL3-7/LDL1-7), the sdLDL/lbLDL ratio (LDL3-7/LDL1-2), and weighted LDL subfraction (LDLSF) scores, were compared between groups. Their associations with insulin resistance, estimated using the homeostasis model assessment of insulin resistance, were examined.
The concentrations of sdLDL particles were significantly higher in subjects with T2D and IFG than in those with NFG (15.78±13.47mg/dl and 14.60±14.33mg/dl, respectively, vs. 12.22±12.31mg/dl). Compared with those with NFG, subjects with IFG or T2D had significantly a higher sdLDL% (15.98±15.26% vs. 19.50±16.21% or 21.46±16.81%, respectively), a higher sdLDL/lbLDL ratio (0.24±0.30 vs. 0.31±0.37 or 0.35±0.39), and a higher LDLSF score (2.08±0.91 vs. 2.30±1.14 or 2.36±1.17). These lipoprotein subfraction parameters had stronger associations with insulin resistance compared to conventional lipid profiles in the IFG and T2D groups.
Atherogenic dyslipidemia is initiated in an early stage of impaired glucose metabolism, when early intervention might be required.
动脉粥样硬化性血脂异常的早期检测至关重要。我们根据葡萄糖代谢状态研究了脂蛋白亚组分参数。
我们招募了1255名未服用降脂药物的受试者,他们的空腹血糖正常(NFG;n = 200,15.9%)、空腹血糖受损(IFG;n = 443,35.3%)或患有2型糖尿病(T2D;n = 612,48.8%)。通过聚丙烯酰胺凝胶电泳测定脂蛋白亚组分(1 - 7),将低密度脂蛋白(LDL)分为大而轻的LDL(lbLDL,LDL1 - 2)和小而密的LDL(sdLDL,LDL3 - 7)。比较了各组之间的脂蛋白亚组分参数,包括sdLDL%(LDL3 - 7/LDL1 - 7)、sdLDL/lbLDL比值(LDL3 - 7/LDL1 - 2)和加权LDL亚组分(LDLSF)得分。研究了它们与使用胰岛素抵抗稳态模型评估法估算的胰岛素抵抗之间的关联。
T2D和IFG受试者的sdLDL颗粒浓度显著高于NFG受试者(分别为15.78±13.47mg/dl和14.60±14.33mg/dl,而NFG受试者为12.22±12.31mg/dl)。与NFG受试者相比,IFG或T2D受试者的sdLDL%显著更高(分别为15.98±15.26% vs. 19.50±16.21%或21.46±16.81%)、sdLDL/lbLDL比值更高(0.24±0.30 vs. 0.31±0.37或(0.35±0.39))以及LDLSF得分更高(2.08±0.91 vs. 2.30±1.14或2.36±1.17)。在IFG和T2D组中,与传统血脂谱相比,这些脂蛋白亚组分参数与胰岛素抵抗的关联更强。
动脉粥样硬化性血脂异常在葡萄糖代谢受损的早期阶段就已开始,此时可能需要进行早期干预。